Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
232
days
Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands – A nationwide study of drug usage and treatment outcomes
Authors
Benno Diekmann; Carolien M. Woolthuis; Maarten F. Corsten; David de Leeuw; Roel B. Fiets; Elena Segarceanu; Fleur M. van der Valk; Tim T. de Waal; Marjan Cruijsen; Eva de Jongh; Tjeerd Snijders; Danielle van Lammeren; Aart Beeker; Alexandra H.E. Herbers; Lidwine Tick; Bas Franken; Nic J.G.M. Veeger; Eric N. van Roon; Mels HoogendoornShow moreShow less
Affiliations
Department of Pharmacotherapy, Epidemiology and Economics, University of Groningen, Groningen, The Netherlands; Department of Internal Medicine, University Medical Center Groningen, The Netherlands; Department of Oncology, Meander Medical Centre, The Netherlands; Department of Internal Medicine, Vrije Universiteit Medical Center, The Netherlands; Department of Oncology, Amphia Hospital Breda, The Netherlands; Department of Oncology, Saint Antonius Hospital Nieuwegein, The Netherlands; Department of Oncology, Onze Lieve Vrouw Gasthuis, Amsterdam, The Netherlands; Department of Oncology, Isala Hospital Zwolle, The Netherlands; Department of Oncology, Catharina Hospital Eindhoven, The Netherlands; Department of Oncology, Albert Schweitzer Hospital Dordrecht, The Netherlands; Department of Oncology, Medisch Spectrum Twente, The Netherlands; Department of Oncology, HAGA Hospital The Hague, The Netherlands; Department of Oncology, Spaarne Gasthuis, Hoofddorp, The Netherlands; Department of Oncology, Jeroen Bosch Hospital, The Netherlands; Department of Oncology, Maxima Medical Centre, Eindhoven, The Netherlands; Department of Internal Medicine, Frisius Medical Centre, Leeuwarden, The Netherlands; Frisius Medical Centre Academy, Frisius Medical Centre, Leeuwarden, The Netherlands; Department of Clinical Pharmacy & Pharmacology, Frisius Medical Centre, Leeuwarden, The NetherlandsShow moreShow less
107
days
Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients
Authors
Tanja C. van Dijk; Marcel Smid; Debbie G.J. Robbrecht; Khrystany T. Isebia; John W.M. Martens; Nick BeijeShow moreShow less
Affiliations
Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, Rotterdam 3015 GD, the NetherlandsShow moreShow less
84
days
Immune remodelling and molecular profiling of progressive brain metastases following cranial radiotherapy
Authors
Ariane Steindl; Angelika M. Starzer; Erwin Tomasich; Markus Kleinberger; Luzia Berchtold; Franziska Eckert; Georg Widhalm; Brigitte Gatterbauer; Johannes A. Hainfellner; Lisa Wozelka-Oltjan; Bekir Erguener; Michael Schuster; Christoph Bock; Gerwin Heller; Matthias Preusser; Anna.S. BerghoffShow moreShow less
Affiliations
Division of Oncology, Department of Medicine I, Medical University of Vienna, Austria; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Division of Oncology, Medical University of Vienna, Austria; Department of Radiation Oncology, Medical University of Vienna, Austria; Department of Neurosurgery, Medical University of Vienna, Austria; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Austria; Department of Pathology, Medical University of Vienna, Vienna, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Institute of Artificial Intelligence, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, AustriaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days